Guardant Health, Inc.
- Last sale
- Nov 12, 2026 · +0.06%
- Market cap
- $20.95B
- 135.29M shares
- Filings
- 1,086
Q3 2026+32.9% FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026derivedN/M FY25 yoy
Q3 2026N/M FY25 yoy
Q3 2026−28.0% FY25 yoy
- $20.95B
- —
- 16.4×
- —
- -1.11%
- —
Twelve months to Sep 30, 2026 · derived
Price
Nov 12, 2026 · IEX last sale
IEX last saleClose of recordAs traded
Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.
Financials
Revenue
| Period | Ended | Value | Kind | Source trail |
|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $982,021,000 | reported | |
| FY 2024 | 2024-12-31 | $739,016,000 | reported | |
| FY 2023 | 2023-12-31 | $563,948,000 | reported | |
| FY 2022 | 2022-12-31 | $449,538,000 | reported | |
| FY 2021 | 2021-12-31 | $373,653,000 | reported | |
| FY 2020 | 2020-12-31 | $286,730,000 | reported | |
| FY 2019 | 2019-12-31 | $214,375,000 | reported | |
| FY 2018 | 2018-12-31 | $90,639,000 | reported | |
| FY 2017 | 2017-12-31 | $49,842,000 | reported | |
| FY 2016 | 2016-12-31 | $25,249,000 | reported |
Capital returns
| Fiscal year | Dividends | Buybacks | Total | Per share | Shares | Shares · yoy | of free cash flow |
|---|---|---|---|---|---|---|---|
| FY2025 | — | $45.01M | $45.01M | — | 131.17M sh | +6.3% | — |
| FY2024 | — | $0.00 | $0.00 | — | 123.42M sh | +1.4% | — |
| FY2023 | — | $0.00 | $0.00 | — | 121.71M sh | +18.6% | — |
| FY2020 | — | $0.00 | $0.00 | — | 100.43M sh | +6.4% | — |
| FY2019 | — | $0.00 | $0.00 | — | 94.38M sh | +10.0% | — |
Segments
LineFY2025ShareChange
United States$923.28M94%+32.4%
International$58.74M6.0%+40.3%
Total$982.02M
Medical laboratories
Guardant Health, Inc. is the 6th largest of the 29 covered companies the SEC files under this code, by revenue. SIC 8071
CompanyRevenueGrowthNet marginMarket cap
FTREFortrea Holdings Inc.$2.7B1.0%36.2%$1.9BNTRANatera, Inc.$2.3B35.9%9.0%$46.8BRDNTRadNet, Inc.$2.0B11.5%0.9%$6.0B
GHGuardant Health, Inc. (this company)$982.0M32.9%42.4%$20.9B
CAICaris Life Sciences, Inc.$812.0M97.0%8.4%$6.9BVCYTVeracyte, Inc.$517.1M16.0%12.8%$2.0BCDNACareDx, Inc.$379.8M13.8%5.6%$4.4BCSTLCastle Biosciences Inc$344.2M3.7%7.0%$1.1BFLGTFulgent Genetics, Inc.$322.7M13.8%18.8%$693.9MPeers are the covered companies filed under the same SIC code, then under codes that share its first three digits or its first two, nearest in revenue first. Figures are each company’s latest fiscal year as filed; market cap is at its latest price.
Guardant Health, Inc. · CIK 1576280 · Engraved from SEC EDGAR